Sunday 24 September
MORNING: SPECIALTY UPDATE SYMPOSIA
11.20-14.30 SPECIAL SESSION: THE COOLEST CLINICAL TRIALS IN TRANSPLANTATION SPONSORED BY THE EU
*** LIMITED SEATS AVAILABLE - PLEASE CLICK HERE TO REGISTER FOR THIS SESSION ***
Since the beginning of transplantation, clinical trials entertained in Europe contributed to the advancement of this exciting field. Not only large multicenter studies executed by pharmaceutical companies but also investigator-driven research is strongly present in Europe and contributing to the advancement of our field. Under the umbrella of the FP7 and HORIZON2020 frameworks of the European Commission, the EU is sponsoring large international research networks, also in transplantation. In this session, we listen to the stories of the protagonists in the EU-sponsored projects in the field of solid organ transplantation, and discuss the opportunities and hurdles encountered by these large international collaborative networks.
CHAIRS: Pierre Marquet, Limoges, France
Maarten Naesens, Leuven, Belgium
11.20 Chairs' Welcome
11.30 EU-funding of innovative approaches to solid organ transplantation
Jürgen Sautter, European Commission, Brussels, Belgium
11.50 ONE - A unified approach to evaluating cellular immunotherapy in solid organ transplantation
Edward K. Geissler, Regensburg, Germany
12.10 Bio-DrIM - Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation
Petra Reinke, Berlin, Germany
12.30-13.10 Networking Lunch
13.10 EUROSTAM - A Europe-wide strategy to enhance transplantation of highly sensitized patients on basis of acceptable HLA mismatches
Frans Claas, Leiden, The Netherlands
13.30 BIOMARGIN - Biomarkers of renal graft injury
Pierre Marquet, Limoges, France
13.50 COPE - Consortium for organ preservation in Europe: latest news
Rutger Ploeg, Oxford, United Kingdom
14.10 - 14:30 Q&A - Questions from the audience and discussion about opportunities for joint activities and important topics for the future of organ transplantation.
13.00-14.30 Corporate plenary symposia
15:00 -17:20 OPENING AND PLENARY SESSION 1 | BIG BANG IN TRANSPLANTATION
The session will take you on a journey from the origins of transplantation to the present day. Recent advances in science open the gate to extending human life, defying nature. However, we are also learning from nature as to how to extend the life of organs and the entire human body. On the brink of the biggest adventure of the human race, stepping on a different planet, we face questions about the very essence of humanity.
CREATED BY: Maarten Naesens, Leuven, Belgium
Gabriel Oniscu, Edinburgh, United Kingdom
CHAIRS: Josep Maria Grinyó, Barcelona, Spain
Vassilios Papalois, London, United Kingdom
15.00 Welcome address by the Congress Chairs
Valentín Cuervas-Mons, Madrid, Spain and Antonio Román, Barcelona, Spain
15.20 ESOT presents: The story of organ transplantation - for patients, with patients
15.30 A patient experience and viewpoint
Carole Lamarque, Antwerp, Belgium
16.00 Hibernation and preservation
Robert H. Henning, Groningen, The Netherlands
16.20 A glimpse into the ongoing/near future of transplantation
Gerald Brandacher, Baltimore, United States
16.45 KEYNOTE: The human fate from a universal perspective - the race to Mars
John Bradford, Atlanta, United States
16.45-18.15 Corporate parallel symposia
17:45-18:45 Transplant International behind the scenes: Ten ways to get your paper (not) rejected
This session will provide insight into how the decision is made whether a submitted paper gets accepted or rejected. To inform about parts of the decision process that are usually not visible to the author. To show examples of pitfalls to avoid when submitting a paper. To provide suggestions how to optimize your chances of acceptance.
CHAIRS: Rainer Oberbauer, Vienna, Austria
Thomas Wekerle, Vienna, Austria
17:45 Introduction
Rainer Oberbauer, Vienna, Austria; Thomas Wekerle, Vienna, Austria
17:55 The editor’s perspective: do's
Rainer Oberbauer, Vienna, Austria
18:15 The editor’s perspective: dont’s
Thomas Wekerle, Vienna, Austria
18:35 Interactive discussion with the audience
17:45 -18:45 Brief oral sessions
e-Poster opening